Clairleaf

BI 1291583 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clairleaf, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine [Phase 2]

See pricing